House’s New ‘Right To Try’ Legislation Ensures FDA’s Oversight Of Terminally Ill Patients Getting Untested Drugs

The House is expected to vote on the legislation this week. Both the Senate and the president have backed the right-to-try movement in the past. Also on Capitol Hill, the Senate is turning its focus on the contentious debate over the 340B drug discount program, the pharmaceutical industry is trying to get lawmakers to undo a deal that would force drugmakers to pick up more of the tab for prescription spending in the Medicare doughnut hole, and Sen. Claire McCaskill (D-Mo.) wants more donations transparency.

from Kaiser Health News http://ift.tt/2DlT9bY